BTC $62,960.60 -0.10%
ETH $1,878.23 -0.28%
BNB $606.04 -0.21%
XRP $0.9994 -0.44%
SOL $75.27 -0.23%
TRX $0.3310 -0.46%
DOGE $0.0695 -0.88%
ADA $0.1761 -2.37%
BCH $203.32 -0.97%
LINK $9.44 -0.78%
HYPE $56.92 +0.92%
AAVE $85.95 -0.62%
SUI $0.6738 -1.66%
XLM $0.1568 -1.24%
ZEC $484.86 -2.23%
BTC $62,960.60 -0.10%
ETH $1,878.23 -0.28%
BNB $606.04 -0.21%
XRP $0.9994 -0.44%
SOL $75.27 -0.23%
TRX $0.3310 -0.46%
DOGE $0.0695 -0.88%
ADA $0.1761 -2.37%
BCH $203.32 -0.97%
LINK $9.44 -0.78%
HYPE $56.92 +0.92%
AAVE $85.95 -0.62%
SUI $0.6738 -1.66%
XLM $0.1568 -1.24%
ZEC $484.86 -2.23%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.